![(1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate in PDB entry 6cju, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/6cju_entity_3_side_image-200x200.png "Homo tetrameric assembly 1 of PDB entry <span class='highlight'>6cju</span> contains 32 copies of <span class='highlight'>(1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate</span>. Side view.")
![(1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate in PDB entry 6cju, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/6cju_entity_3_top_image-200x200.png "Homo tetrameric assembly 1 of PDB entry <span class='highlight'>6cju</span> contains 32 copies of <span class='highlight'>(1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate</span>. Top view.")
Environment details NEW
PGW 501 bound to chain B
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.